Skip to main content
KPRX
NASDAQ Life Sciences

Kiora's KIO-300 Shows Significant Seizure Suppression in Preclinical Epilepsy Model

Tom Rudovsky · Reported by TMX Newsfile
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.57
Mkt Cap
$11.39M
52W Low
$1.765
52W High
$3.29
52W Position info
46% above low
Off High info
22% below high
Rel. Volume
Market data snapshot near publication time

KPRX sits 46% above its 52-week low of $1.765.

Summary

Kiora Pharmaceuticals reported positive preclinical data for its drug candidate KIO-300, demonstrating significant suppression of seizure activity in an ex vivo epilepsy model. This expands the potential therapeutic applications of KIO-300 beyond its current Phase 2 program for vision restoration. The findings suggest a broader utility for the company's ion channel modulator platform in neurological disorders.

At the time of this announcement, KPRX was trading at $2.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.4M. The 52-week trading range was $1.76 to $3.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.


Price Chart

Share this article

Copied!

KPRX - Latest Insights

KPRX
Nov 12, 2026, 7:01 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $0.7346 info
Change: -$0.6654 (-48%) info
Market Cap: $3.186M info
KPRX
Oct 29, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.58
Real-time Price: $0.7346 info
Change: -$1.85 (-72%) info
Market Cap: $3.186M info
KPRX
Aug 19, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.65
Real-time Price: $0.7346 info
Change: -$1.92 (-72%) info
Market Cap: $3.186M info
KPRX
Aug 07, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.58
Real-time Price: $0.7346 info
Change: -$1.85 (-72%) info
Market Cap: $3.186M info
KPRX
Jun 18, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.57
Real-time Price: $0.7346 info
Change: -$1.84 (-71%) info
Market Cap: $3.186M info